KATHARINE JURGENSEN: Open Payments
NPI 1366842809 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,517 in 145 payments from 36 companies in 2025. Trend: 2023 $3,656 · 2024 $3,340 · 2025 $3,517
Food & beverage: $3,363Education: $154
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $389 |
| ABBVIE INC. | 19 | $282 |
| PFIZER INC. | 14 | $257 |
| HARMONY BIOSCIENCES LLC | 7 | $221 |
| Janssen Biotech, Inc. | 5 | $158 |
| SK Life Science, Inc. | 5 | $153 |
| Biogen, Inc. | 6 | $143 |
| CATALYST PHARMACEUTICALS, INC. | 5 | $137 |
| ARGENX US, INC. | 5 | $134 |
| Genentech USA, Inc. | 4 | $124 |
Products named: NURTEC ODT, WAKIX, Fintepla, FYCOMPA, QULIPTA, Ocrevus Zunovo, ZEPOSIA, INGREZZA.
Industry payments across GA — which companies pay providers there.
